| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 06/15/2005 | EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 06/15/2005 | EP1341797A4 Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catayltic reactions |
| 06/15/2005 | EP1256576B1 Fused imidazolium derivatives |
| 06/15/2005 | CN1206213C N-arylsulfonyl amino acid omega amides |
| 06/14/2005 | US6906094 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase |
| 06/14/2005 | US6906092 Method of inhibiting matrix metalloproteinases |
| 06/14/2005 | CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/09/2005 | WO2005051914A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/09/2005 | WO2005051900A1 Novel compounds for the treatment of obesity |
| 06/09/2005 | WO2005051898A2 Vitamin d receptor modulators |
| 06/09/2005 | WO2005051897A1 Process for the preparation of tamsulosin |
| 06/09/2005 | WO2005035485A3 Analgesic compounds, their synthesis and pharmaceutical compositions containing them |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/09/2005 | US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050124001 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 06/09/2005 | US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions |
| 06/09/2005 | US20050123533 Prodrugs activated by targeted catalytic proteins |
| 06/09/2005 | CA2546142A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/08/2005 | EP1538150A1 Novel pleuromutilin derivatives |
| 06/08/2005 | EP1537125A1 Method for the organometallic production of organic intermediate products comprising carbon-heteroatom bonds achieved by the deprotonation of heteroatoms |
| 06/08/2005 | EP1537074A1 Cathepsin cysteine protease inhibitors |
| 06/08/2005 | EP1537066A2 Improvements in pharmaceutically useful compounds |
| 06/08/2005 | EP1042305B1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
| 06/08/2005 | EP0849256B1 Amide compounds and use of the same |
| 06/08/2005 | CN1623988A Biaryl sulfonamides and methods for using same |
| 06/08/2005 | CN1205192C Acylated amino-benzenesulfonyl urea, its prepn .and as herbicide and plant-growth regulator |
| 06/08/2005 | CN1205184C Beta-lactan |
| 06/08/2005 | CN1205180C 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 06/07/2005 | US6903135 Methods and products related to 16-HETE analogs |
| 06/07/2005 | US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 06/07/2005 | US6903114 Carbocyclic alcohols such as 1,6-dinitronaphthalene-2,3-diol, used as catechol-O-methyltransferase inhibitors, for prophylaxis of Parkinson's disease |
| 06/02/2005 | WO2005049594A1 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | WO2005049593A2 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | WO2005049590A2 N-sulfonylaminocarbonyl containing compounds |
| 06/02/2005 | WO2005049553A1 N-substituted p-menthane carbosamided |
| 06/02/2005 | US20050119504 New process for the preparation of a biphenyl ether compound |
| 06/02/2005 | US20050119333 Compositions comprising ether compounds and pharmaceutical uses therefor |
| 06/02/2005 | US20050119316 Semicarbazide derivatives and the use thereof as antithrombotics |
| 06/02/2005 | US20050119305 N-hydroxy-6-[(4-phenylbenzoyl)amino]hexanamide; hydroxamic acid derivative and equivalent thereof; antiinflammatory, anticarcinogenic, antiarthritic, antidiabetic agents; sepsis, leukemia, osteoporosis, skin disorders, cachexia, autoimmune diseases, hepatitis, endometriosis; hypergammaglobulinemia |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534671A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 06/01/2005 | EP1534666A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 06/01/2005 | EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/01/2005 | EP1534284A2 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 06/01/2005 | EP1534259A2 Sulfonamides as potassium channel blockers |
| 06/01/2005 | EP1351959B1 Novel pleuromutilin derivatives |
| 06/01/2005 | EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 06/01/2005 | EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP1058553B1 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy |
| 06/01/2005 | EP0993441B1 INHIBITORS OF p38 |
| 06/01/2005 | CN1203898C Perfluoroalkyl-containing metal complexes, its preparing method and use in NMR diagnostics |
| 05/31/2005 | US6900353 Cyclopentyl sulfonamide derivatives |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/31/2005 | US6900237 Sulfonamide compounds as protease inhibitors |
| 05/31/2005 | US6900231 Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 05/26/2005 | US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/26/2005 | US20050113567 Chemical intermediates for agricultural chemical of perfluoroisopropyl benzene derivtives and raw materials and agricultural compounds |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113442 Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides derivatives |
| 05/26/2005 | US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 05/26/2005 | US20050113346 making sulfur compounds such as 2-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-N-hydroxy-3-methyl -butyramide, used as tumor necrosis factor-alpha converting enzyme (TACE) inhibitors, for prophylaxis of rheumatic diseases, sepsis or inflammation |
| 05/26/2005 | US20050112672 Immobilization of compounds with connector groups of amines |
| 05/26/2005 | CA2451175A1 Process for the preparation of tamsulosin |
| 05/25/2005 | EP1533294A1 Beta-alanine derivative and use thereof |
| 05/25/2005 | EP1532102A1 Cosmetic or dermopharmaceutical compositions comprising tyramine derivatives, method for preparing same, and use thereof |
| 05/25/2005 | DE10348022A1 Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases |
| 05/25/2005 | CN1620424A Compounds for the treatment of inflammatory disorders |
| 05/25/2005 | CN1620292A Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors |
| 05/24/2005 | US6897237 MMP-12 inhibitors |
| 05/24/2005 | US6897220 Antiproliferative agents |
| 05/24/2005 | US6897209 Thrombosis; anticholesterol agents; cardiovascular disorders; antiinflammatory agents; anticancer agents |
| 05/19/2005 | WO2005044795A1 Process for the preparation of ccr-2 antagonist |
| 05/19/2005 | WO2005044787A1 Phenetanolamine derivatives |
| 05/19/2005 | WO2005044782A1 Diimonium salt compound and use thereof |
| 05/19/2005 | WO2005044007A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient |
| 05/19/2005 | WO2005012220A9 Cycloalkylidene compounds as modulators of estrogen receptor |
| 05/19/2005 | WO2004092100A8 Indene derivatives as pharmaceutical agents |
| 05/19/2005 | US20050107615 Immobilization of compounds with connector groups of amines |
| 05/19/2005 | US20050107448 Calcium receptor antagonists |
| 05/19/2005 | US20050107445 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis |
| 05/19/2005 | US20050107444 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/19/2005 | US20050107354 Preventive or therapeutic agent for kidney disease |
| 05/19/2005 | US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/19/2005 | CA2543237A1 Diimonium salt compound and use thereof |
| 05/18/2005 | EP1176139B1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors |
| 05/18/2005 | CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/18/2005 | CN1615833A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/18/2005 | CN1202104C 2-phenylpyran-4-one derivatives |
| 05/17/2005 | US6894188 Adrenergic nblocking agent; benign prostatic hyperplasma |
| 05/17/2005 | US6894172 Stereospecific catalysts comprising chelate compounds used for alkylation, reduction, cyclization, hydrogenation, amination, epoxidation, aldol or Michael condensations |
| 05/17/2005 | US6894063 Drugs for treating metabolic and eating disorders, diabetes |
| 05/17/2005 | CA2136597C Hydrazine derivatives and uses thereof |
| 05/12/2005 | WO2005042513A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 05/12/2005 | WO2005021490A3 N-SULFONYL-α-AMINO-ACID DERIVATIVES |
| 05/12/2005 | WO2005019164A3 Preparation of phenethanolamine derivatives |
| 05/12/2005 | WO2005014539A3 Pyrrole-based hmg-coa reductase inhibitors |
| 05/12/2005 | WO2004092145A8 Alpha substituted carboxylic acid as ppar modulators |
| 05/12/2005 | WO2004072087A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |